Technivie

Active Ingredient(s): Ombitasavir + Paritaprevir + Ritonavir
FDA Approved: * July 24, 2015
Pharm Company: * ABBVIE INC
Category: Hepatitis

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Technivie Overview

Ombitasvir/paritaprevir/ritonavir, sold under the brand names Technivie and Viekira Pak among others, is a medication used to treat hepatitis C.[1] It is a fixed dose combination of ombitasvir, paritaprevir, and ritonavir.[1] Specifically it is used together with dasabuvir or ribavirin for cases caused by hepatitis C virus genotype 1 or 4.[1][2] Cure rates are around 95%.[2] It is taken by mouth.[1]...

Read more Technivie Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Ombitasvir/paritaprevir/ritonavir

Recent Technivie Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Ombitasavir + Paritaprevir + Ritonavir
  • Tablet: 12.5mg + 75mg + 50mg
  • Tablet, Extended Release: 200mg + 8.33mg + 50mg + 33.33mg
  • Tablet, Tablet: 12.5mg + 75mg + 50mg + 250mg, 250mg,n/a,n/a,n/a + N/a,12.5mg,75mg,50mg
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Technivie: (1 result)

Sorted by National Drug Code

Drugs with one or more similar ingredients: (8 results)






Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 19 January 2019.

We are committed to your privacy.

Copyright © 2005-2019 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA